Common susceptibility alleles and SQSTM1 mutations predict disease extent and severity in a multinational study of patients with Paget's disease

Journal of Bone and Mineral Research

Volumn 28, Issue 11, 2013, Pages 2338-2346

  Albagha, Omar M E ^a   Visconti, Micaela Rios ^a   Alonso, Nerea ^a   Wani, Sachin ^a   Goodman, Kirsteen ^b   Fraser, William D ^c   Gennari, Luigi ^d   Merlotti, Daniela ^d   Gianfrancesco, Fernando ^e   Esposito, Teresa ^e   Rendina, Domenico ^f   Di Stefano, Marco ^g   Isaia, Giancarlo ^g   Brandi, Maria Luisa ^h   Giusti, Francesca ^h   Del Pino Montes, Javier ⁱ   Corral Gudino, Luis ^j   Gonzalez Sarmiento, Rogelio ⁱ   Ward, Lynley ^k   Rea, Sarah L ^l   Ratajczak, Thomas ^k,l   Walsh, John P ^k,m   Ralston, Stuart H ^a,b   more..

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^d UNIVERSITY OF SIENA   (Italy)

^e INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

^f UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^g UNIVERSITY OF TURIN   (Italy)

^h UNIVERSITY OF FLORENCE   (Italy)

ⁱ UNIVERSITY OF SALAMANCA   (Spain)

^j HOSPITAL EL BIERZO   (Spain)

^k SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^l UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^m UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

more..

Author keywords

GENETICS; PAGET'S DISEASE OF BONE; SQSTM1

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; ETIDRONIC ACID; PAMIDRONIC ACID; PROTEIN DERIVATIVE; RISEDRONIC ACID; SQSTM1 PROTEIN; TILUDRONIC ACID; UNCLASSIFIED DRUG; ZOLEDRONIC ACID;

ADOLESCENT; ALLELE; ARTICLE; AUSTRALIA; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; EARLY INTERVENTION; FEMALE; GENE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PAGET BONE DISEASE; PREDICTION; SCORING SYSTEM; SPAIN; SQSTM1 GENE; UNITED KINGDOM;

GENETICS; PAGET'S DISEASE OF BONE; SQSTM1;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AGED; ALLELES; BIOLOGICAL MARKERS; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERNATIONALITY; MALE; META-ANALYSIS AS TOPIC; MIDDLE AGED; MUTATION; OSTEITIS DEFORMANS; RISK FACTORS; TREATMENT OUTCOME;

EID: 84886849957     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.1975     Document Type: Article

References (31)

1. van Staa TP, Selby P, Leufkens HG, Lyles K, Sprafka JM, Cooper C., Incidence and natural history of Paget's disease of bone in England and Wales. J Bone Miner Res. 2002; 17: 465-71.
2. Langston AL, Campbell MK, Fraser WD, Maclennan G, Selby P, Ralston SH., Clinical determinants of quality of life in Paget's disease of bone. Calcif Tissue Int. 2007; 80: 1-9.
3. Gold DT, Boisture J, Shipp KM, Pieper CF, Lyles KW., Paget's disease of bone and quality of life. J Bone Miner Res. 1996; 11: 1897-04.
4. Laurin N, Brown JP, Morissette J, Raymond V., Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone. Am J Hum Genet. 2002; 70: 1582-8.
5. Hocking LJ, Lucas GJA, Daroszewska A, Mangion J, Olavesen M, Nicholson GC, Ward L, Bennett ST, Wuyts W, Van Hul W, Ralston SH., Domain specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget's disease. Hum Mol Genet. 2002; 11: 2735-9.
6. Daroszewska A, van't Hof RJ, Rojas JA, Layfield R, Landao-Basonga E, Rose L, Rose K, Ralston SH., A point mutation in the ubiquitin associated domain of SQSMT1 is sufficient to cause a Paget's disease like disorder in mice. Hum Mol Genet. 2011; 20: 2734-44.
7. Kurihara N, Hiruma Y, Zhou H, Subler MA, Dempster DW, Singer FR, Reddy SV, Gruber HE, Windle JJ, Roodman GD., Mutation of the sequestosome 1 (p62) gene increases osteoclastogenesis but does not induce Paget disease. J Clin Invest. 2007; 117: 133-42.
8. Hocking LJ, Lucas GJA, Daroszewska A, Cundy T, Nicholson GC, Donath J, Walsh JP, Finlayson C, Cavey JR, Ciani B, Sheppard PW, Searle MS, Layfield R, Ralston SH., Novel UBA domain mutations of SQSTM1 in Paget's disease of bone: genotype phenotype correlation, functional analysis and structural consequences. J Bone Miner Res. 2004; 19: 1122-7.
9. Falchetti A, Di Stefano M, Marini F, Ortolani S, Ulivieri MF, Bergui S, Masi L, Cepollaro C, Benucci M, Di MO, Rossini M, Adami S, Del PA, Isaia G, Torricelli F, Brandi ML., Genetic epidemiology of Paget's disease of bone in Italy: sequestosome1/p62 gene mutational test and haplotype analysis at 5q35 in a large representative series of sporadic and familial Italian cases of Paget's disease of bone. Calcif Tissue Int. 2009; 84: 20-37.
10. Beyens G, Van Hul E, Van Driessche K, Fransen E, Devogelaer JP, Vanhoenacker F, Van Offel J, Verbruggen L, De Clerck L, Westhovens R, Van Hul W., Evaluation of the role of the SQSTM1 gene in sporadic Belgian patients with Paget's disease. Calcif Tissue Int. 2004; 75: 144-52.
11. Good DA, Busfield F, Fletcher BH, Lovelock PK, Duffy DL, Kesting JB, Andersen J, Shaw JT., Identification of SQSTM1 mutations in familial Paget's disease in Australian pedigrees. Bone. 2004; 35: 277-82.
12. Collet C, Michou L, Audran M, Chasseigneaux S, Hilliquin P, Bardin T, Lemaire I, Cornelis F, Launay JM, Orcel P, Laplanche JL., Paget's disease of bone in the French population: novel SQSTM1 mutations, functional analysis, and genotype-phenotype correlations. J Bone Miner Res. 2007; 22: 310-7.
13. Johnson-Pais TL, Wisdom JH, Weldon KS, Cody JD, Hansen MF, Singer FR, Leach RJ., Three novel mutations in SQSTM1 identified in familial Paget's disease of bone. J Bone Miner Res. 2003; 18: 1748-53.
14. Eekhoff EW, Karperien M, Houtsma D, Zwinderman AH, Dragoiescu C, Kneppers AL, Papapoulos SE., Familial Paget's disease in The Netherlands: occurrence, identification of new mutations in the sequestosome 1 gene, and their clinical associations. Arth Rheum. 2004; 50: 1650-4.
15. Albagha OME, Wani S, Visconti MR, Alonso N, Goodman K, Cundy T, Brandi ML, Chung PY, Dargie R, Devogelaer JP, Falchetti A, Fraser WD, Gennari L, Gianfrancesco F, Hooper MJ, Van Hul W, Isaia G, Nicholson GC, Nuti R, Del Pino MJ, Ratajczak T, Rea SL, Rendina D, Gonzalez-Sarmiento R, Di SM, Ward L, Walsh JP, Ralston SH., Genome-wide association identifies three new susceptibility loci for Paget's disease of bone. Nat Genet. 2011; 43: 685-9.
16. Albagha OM, Visconti MR, Alonso N, Langston AL, Cundy T, Dargie R, Dunlop MG, Fraser WD, Hooper MJ, Isaia G, Nicholson GC, Del Pino MJ, Gonzalez-Sarmiento R, Di SM, Tenesa A, Walsh JP, Ralston SH., Genome-wide association study identifies variants at CSF1, OPTN and TNFRSF11A as genetic risk factors for Paget's disease of bone. Nat Genet. 2010; 42: 520-4.
17. Langston AL, Campbell MK, Fraser WD, MacLennan GS, Selby PL, Ralston SH., Randomised trial of intensive bisphosphonate treatment versus symptomatic management in Paget's disease of bone. J Bone Miner Res. 2010; 25: 20-31.
18. Gennari L, Gianfrancesco F, Di Stefano M, Rendina D, Merlotti D, Esposito T, Gallone S, Fusco P, Rainero I, Fenoglio P, Mancini M, Martini G, Bergui S, De Filippo G, Isaia G, Strazzullo P, Nuti R, Mossetti G., SQSTM1 gene analysis and gene-environment interaction in Paget's disease of bone. J Bone Miner Res. 2010; 25: 1375-84.
19. Corral-Gudino L, Garcia-Aparicio J, Sanchez-Gonzalez MD, Miron-Canelo JA, Blanco JF, Ralston SH, Del Pino-Montes J., Secular changes in Paget's disease: contrasting changes in the number of new referrals and in disease severity in two neighboring regions of Spain. Osteoporos Int. 2013; 24: 443-50.
20. Rea SL, Walsh JP, Ward L, Magno AL, Ward BK, Shaw B, Layfield R, Kent GN, Xu J, Ratajczak T., Sequestosome 1 mutations in Paget's disease of bone in Australia: prevalence, genotype/phenotype correlation and a novel non-UBA domain mutation (P364S) associated with increased NF-kappaB signaling without loss of ubiquitin-binding. J Bone Miner Res. 2009; 24: 1216-23.
21. Ware JE Jr, Gandek B., Overview of the SF-36 health survey and the International Quality of Life Assessment (IQOLA) project. J Clin Epidemiol. 1998; 51: 903-12.
22. Visconti MR, Langston AL, Alonso N, Goodman K, Selby PL, Fraser WD, Ralston SH., Mutations of SQSTM1 are associated with severity and clinical outcome in Paget's disease of bone. J Bone Miner Res. 2010; 25: 2368-73.
23. Morissette J, Laurin N, Brown JP., Sequestosome 1: mutation frequencies, haplotypes, and phenotypes in familial Paget's disease of bone. J Bone Miner Res. 2006; 21 (Suppl 2): 38-44.
24. Gianfrancesco F, Rendina D, Di SM, Mingione A, Esposito T, Merlotti D, Gallone S, Magliocca S, Goode A, Formicola D, Morello G, Layfield R, Frattini A, De Filippo G, Nuti R, Searle M, Strazzullo P, Isaia G, Mossetti G, Gennari L., A non-synonymous TNFRSF11A variation increases NFkB activity and the severity of Paget's disease. J Bone Miner Res. 2011; 27: 443-52.
25. Bolland MJ, Tong PC, Naot D, Callon KE, Wattie DJ, Gamble GD, Cundy T., Delayed development of Paget's disease in offspring inheriting SQSTM1 mutations. J Bone Miner Res. 2007; 22: 411-5.
26. Cundy HR, Gamble G, Wattie D, Rutland M, Cundy T., Paget's disease of bone in New Zealand: continued decline in disease severity. Calcif Tissue Int. 2004; 75: 358-64.
27. Ralston SH, Layfield R., Pathogenesis of Paget disease of bone. Calcif Tissue Int. 2012; 91: 97-113.
28. Reid IR, Miller P, Lyles K, Fraser W, Brown JP, Saidi Y, Mesenbrink P, Su G, Pak J, Zelenakas K, Luchi M, Richardson P, Hosking D., Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease. N Engl J Med. 2005; 353: 898-08.
29. Singer FR, Clemens TL, Eusebio RA, Bekker PJ., Risedronate, a highly effective oral agent in the treatment of severe Paget's disease. J Clin Endocrinol Metab. 1998; 83: 1906-10.
30. Reid IR, Lyles K, Su G, Brown J, Walsh J, Del Pino-Montes J, Miller P, Fraser W, Cafoncelli S, Bucci-Rechtweg C, Hosking D., A single infusion of zoledronic acid produces sustained remissions in Paget's disease-data to 6.5 years. J Bone Miner Res. 2011; 26: 2261-70.
31. Ralston SH., Clinical practice. Paget's disease of bone. N Engl J Med. 2013; 368: 644-50.